Free · no account · quoted from the filing

What changed in OXY's 10-Q

Source: 10-Q filed 2026-05-05 · compared against 10-Q 2025-11-10. Every passage below is quoted verbatim from the filing itself.

OxyChem Sale

This filing

the sale of all of the issued and outstanding equity interests in OxyChem to Berkshire Hathaway…closed on January 2, 2026

Liquidity & Debt

This filing

Cash and cash equivalents $3,811

Tax Dispute

This filing

The IRS is currently reviewing the legal entity reorganization transaction as part of the Company’s 2022 federal tax audit.

Equity & Warrants

This filing

$79 million of cash was received in the first three months of 2026 from the exercise of common stock warrants

What it means — the analyst reading

The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel, plus 1 further change without a quotable passage — is part of the Filing Change Monitor.

See the Filing Change Monitor →

Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.